Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

Overview of attention for article published in Frontiers in Neurology, March 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 95 Dimensions

Readers on

mendeley: 120 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 10,675 followers.

RT @FrontNeurol: Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GF…

04 Apr 2019

Reply Repost Favourite

RT @FrontNeurol: Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GF…

04 Apr 2019

Reply Repost Favourite

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?: Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas-Rodríguez, Marc Suárez-Calvet, Uwe K. Zettl,… http

04 Apr 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.